Q8K3W3
Gene name |
Casc3 (Mln51) |
Protein name |
Protein CASC3 |
Names |
Cancer susceptibility candidate gene 3 protein homolog, Metastatic lymph node gene 51 protein homolog, MLN 51 homolog, Protein barentsz, Btz, mBtz |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:192160 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q8K3W3
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q8K3W3-F1 | Predicted | AlphaFoldDB |
36 variants for Q8K3W3
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs238376883 | 63 | V>L | No | EVA | |
| rs3389210403 | 100 | E>K | No | EVA | |
| rs3389161672 | 119 | D>E | No | EVA | |
| rs3389199062 | 125 | A>E | No | EVA | |
| rs3389161659 | 135 | S>Y | No | EVA | |
| rs3389186470 | 150 | E>D | No | EVA | |
| rs3389210470 | 153 | E>K | No | EVA | |
| rs3389133824 | 163 | G>D | No | EVA | |
| rs3389133759 | 169 | D>V | No | EVA | |
| rs3389161696 | 189 | D>Y | No | EVA | |
| rs3389161671 | 192 | G>V | No | EVA | |
| rs3402983702 | 207 | K>IFP* | No | EVA | |
| rs3389210411 | 218 | D>G | No | EVA | |
| rs3389210491 | 228 | K>T | No | EVA | |
| rs3389199089 | 253 | R>Q | No | EVA | |
| rs3389214924 | 287 | N>K | No | EVA | |
| rs3389202917 | 317 | K>N | No | EVA | |
| rs3389169578 | 340 | L>R | No | EVA | |
| rs3389203161 | 343 | E>D | No | EVA | |
| rs245461399 | 393 | D>E | No | EVA | |
| rs3389133849 | 410 | K>E | No | EVA | |
| rs256421968 | 450 | V>I | No | EVA | |
| rs3389200027 | 471 | W>R | No | EVA | |
| rs3389186484 | 472 | S>N | No | EVA | |
| rs27040992 | 474 | S>G | No | EVA | |
| rs3389133823 | 493 | M>I | No | EVA | |
| rs3389199100 | 503 | R>Q | No | EVA | |
| rs3389200409 | 503 | R>W | No | EVA | |
| rs3389214950 | 532 | P>S | No | EVA | |
| rs3389200072 | 533 | V>A | No | EVA | |
| rs3389169583 | 599 | V>A | No | EVA | |
| rs3389200403 | 651 | A>T | No | EVA | |
| rs214847108 | 653 | P>S | No | EVA | |
| rs3389173586 | 654 | Q>* | No | EVA | |
| rs3389200460 | 657 | G>R | No | EVA | |
| rs246160243 | 696 | G>S | No | EVA |
No associated diseases with Q8K3W3
No regional properties for Q8K3W3
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| No domain, repeats, and functional sites for Q8K3W3 | |||
Functions
10 GO annotations of cellular component
| Name | Definition |
|---|---|
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytoplasmic stress granule | A dense aggregation in the cytosol composed of proteins and RNAs that appear when the cell is under stress. |
| dendrite | A neuron projection that has a short, tapering, morphology. Dendrites receive and integrate signals from other neurons or from sensory stimuli, and conduct nerve impulses towards the axon or the cell body. In most neurons, the impulse is conveyed from dendrites to axon via the cell body, but in some types of unipolar neuron, the impulse does not travel via the cell body. |
| exon-exon junction complex | A multi-subunit complex deposited by the spliceosome upstream of messenger RNA exon-exon junctions. The exon-exon junction complex provides a binding platform for factors involved in mRNA export and nonsense-mediated mRNA decay. |
| nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
| nuclear speck | A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy. |
| nucleus | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| perinuclear region of cytoplasm | Cytoplasm situated near, or occurring around, the nucleus. |
| ribonucleoprotein complex | A macromolecular complex that contains both RNA and protein molecules. |
| U2-type catalytic step 1 spliceosome | A spliceosomal complex that is formed by the displacement of the U1 and U4 snRNPs from the precatalytic spliceosome; the U2, U5 and U6 snRNPs remain associated with the mRNA. This complex, sometimes called the activated spliceosome, is the catalytically active form of the spliceosome, and includes many proteins in addition to those found in the U2, and U5 and U6 snRNPs. |
4 GO annotations of molecular function
| Name | Definition |
|---|---|
| enzyme binding | Binding to an enzyme, a protein with catalytic activity. |
| identical protein binding | Binding to an identical protein or proteins. |
| mRNA binding | Binding to messenger RNA (mRNA), an intermediate molecule between DNA and protein. mRNA includes UTR and coding sequences, but does not contain introns. |
| ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
6 GO annotations of biological process
| Name | Definition |
|---|---|
| intracellular mRNA localization | Any process in which mRNA is transported to, or maintained in, a specific location within the cell. |
| mRNA export from nucleus | The directed movement of mRNA from the nucleus to the cytoplasm. |
| mRNA splicing, via spliceosome | The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced. |
| nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | The nonsense-mediated decay pathway for nuclear-transcribed mRNAs degrades mRNAs in which an amino-acid codon has changed to a nonsense codon; this prevents the translation of such mRNAs into truncated, and potentially harmful, proteins. |
| regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | Any process that modulates the frequency, rate or extent of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay. |
| regulation of translation | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
No homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| No homologous proteins | ||||
| 10 | 20 | 30 | 40 | 50 | 60 |
| MADRRRQRAS | QDTEDEESGA | SGSDSGSPAR | GGGSCSGSVG | GGGSGSLPSQ | RGGRGGGLHL |
| 70 | 80 | 90 | 100 | 110 | 120 |
| RRVESGGAKS | AEESECESED | GMEGDAVLSD | YESAEDSEGE | EDYSEEENSK | VELKSEANDA |
| 130 | 140 | 150 | 160 | 170 | 180 |
| ADSSAKEKGE | EKPESKGTVT | GERQSGDGQE | STEPVENKVG | KKGPKHLDDD | EDRKNPAYIP |
| 190 | 200 | 210 | 220 | 230 | 240 |
| RKGLFFEHDL | RGQTQEEEVR | PKGRQRKLWK | DEGRWEHDKF | REDEQAPKSR | QELIALYGYD |
| 250 | 260 | 270 | 280 | 290 | 300 |
| IRSAHNPDDI | KPRRIRKPRF | GSSPQRDPNW | IGDRSSKSHR | HQGPGGNLPP | RTFINRNTAG |
| 310 | 320 | 330 | 340 | 350 | 360 |
| TGRMSASRNY | SRSGGFKDGR | TSFRPVEVAG | QHGGRSAETL | KHEASYRSRR | LEQTPVRDPS |
| 370 | 380 | 390 | 400 | 410 | 420 |
| PEPDAPLLGS | PEKEEVASET | PAAVPDITPP | APDRPIEKKS | YSRARRTRTK | VGDAVKAAEE |
| 430 | 440 | 450 | 460 | 470 | 480 |
| VPPPSEGLAS | TATVPETTPA | AKTGNWEAPV | DSTTGGLEQD | VAQLNIAEQS | WSPSQPSFLQ |
| 490 | 500 | 510 | 520 | 530 | 540 |
| PRELRGVPNH | IHMGAGPPPQ | FNRMEEMGVQ | SGRAKRYSSQ | RQRPVPEPPA | PPVHISIMEG |
| 550 | 560 | 570 | 580 | 590 | 600 |
| HYYDPLQFQG | PIYTHGDSPA | PLPPQGMIVQ | PEMHLPHPGL | HPHQSPGPLP | NPGLYPPPVS |
| 610 | 620 | 630 | 640 | 650 | 660 |
| MSPGQPPPQQ | LLAPTYFSAP | GVMNFGNPNY | PYAPGALPPP | PPPHLYPNTQ | APPQVYGGVT |
| 670 | 680 | 690 | |||
| YYNPAQQQVQ | PKPSPPRRTP | QPVSIKPPPP | EVVSRGSS |